A targeted intervention project for people who inject drugs is being reviewed under NACP. Beyond needle-syringe exchange and condom distribution, which biomedical component is specifically provided to reduce opioid dependence and injecting behaviour?
- A Opioid substitution therapy with buprenorphine or methadone ✓
- B Monthly injectable naltrexone depot preparations
- C Short-course directly observed antiretroviral prophylaxis
- D Interferon-based therapy for hepatitis C coinfection
Correct answer: A. Opioid substitution therapy with buprenorphine or methadone
Explanation
Opioid substitution therapy using oral buprenorphine or methadone is an established component of NACP targeted interventions for people who inject drugs, delivered alongside needle-syringe exchange, condoms and referral for HIV and viral hepatitis testing. Naltrexone is an antagonist used for relapse prevention in deaddiction settings rather than OST, and neither ART prophylaxis nor interferon therapy forms part of the TI package.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.